The US healthcare system doesn't have a pricing problem - it has a transparency problem.
And those are not the same thing.
Imagine buying a home without ever seeing the purchase price. The seller knows the price. The lender knows. The broker knows. The appraiser knows. You're the only person expected to make one of the biggest financial decisions of your life without understanding the economics behind it.
We'd never accept that - yet we've accepted something remarkably similar in healthcare.
For decades, we've accepted a marketplace where almost everyone knows the price—except the people actually paying for it. Manufacturers know. PBMs know. Wholesalers know. Health systems know. Payers know. Consultants know. Yet somehow, the patient, employer, and especially the physician are left trying to piece together a puzzle that should never have been a mystery in the first place.
That isn't an accident.
There is money to be made in confusion.
When prices are difficult to compare, negotiations become invisible. When incentives remain hidden, accountability fades. When no one can clearly explain why one therapy costs ten times more than another, the status quo wins.
Confusion creates friction.
Friction creates dependence.
And dependence creates profit.
Healthcare has become remarkably sophisticated at measuring outcomes, but surprisingly poor at explaining costs. We celebrate innovation in medicine while accepting opacity in the marketplace.
In every other industry, transparency builds confidence. In healthcare, we've somehow learned to accept the opposite. Yet we've normalized it in one of the most important sectors of our economy.
Transparency isn't about pointing fingers. It isn't about blaming manufacturers, insurers, hospitals, or distributors. Every participant operates within incentives that have evolved over decades.
The problem isn't that one group is bad.
The problem is that the system rewards complexity more than clarity.
Complexity has value—for those who understand it.
Everyone else pays the price.
Consider an oncology practice evaluating two therapies. The clinical data may be clear, but understanding the true economics (pricing, reimbursement, contracting, and distribution costs) for both the Patient and Provider often is not.
Clinical decisions are clouded by financial ambiguity.
That's why I believe the next era of healthcare won't be defined solely by breakthrough therapies. It will be defined by breakthrough visibility. The organizations that earn trust won't just deliver better treatments. They'll make it easier for people to understand what they're buying, why it costs what it does, and what alternatives exist.
Trust begins where mystery ends.
At Prism TPO, that belief is foundational. Transparency isn't a marketing slogan or a compliance exercise. It's a philosophy. Every conversation about pricing should answer the same basic questions: What is this? Why does it cost this much? Who benefits? What are the trade-offs? If we can't answer those questions simply, then we've failed before the discussion even begins.
The industry often says healthcare is complicated - it is. But there’s a difference between complicated and confusing.
Patients don't expect every spreadsheet. Employers don't need every contract. Physicians don't want to become financial analysts. What they deserve is information that's understandable, comparable, and actionable. Clarity doesn't eliminate complexity—it translates it.
The irony is that transparency doesn't destroy value, it creates it.
When markets become more transparent, the best products win. The best service wins. The best outcomes win. Companies compete on innovation instead of information asymmetry. That's how healthy markets are supposed to work.
Some fear transparency because they believe it will compress margins.
I believe it expands trust.
And trust compounds faster than almost anything else in business.
Employers are asking harder questions. Physicians expect better tools. Patients increasingly want to understand not only their care, but the economics behind it. Transparency is no longer a buzz word—it is quickly becoming a competitive necessity.
The future of healthcare belongs to organizations willing to explain, not obscure. To educate, not overwhelm. To simplify, not complicate.
Because in the end, confusion is expensive - and not just financially. It costs confidence. It costs credibility. And sometimes, it costs better decisions.
For too long, opacity has been treated as a competitive advantage.
I think transparency is the better one.
The companies that embrace it won't just lead the next chapter of healthcare.
They'll write it.